Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells
Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells
复制标题
HTLV-I p40Tax 蛋白下调的原代成体 T 细胞白血病细胞的粘附依赖性生长:急性 ATL 细胞生长的新型体外模型
DOI:
10.1007/s12185-008-0207-z
复制
发表时间:
2008
影响因子:
2.1
通讯作者:
M. Tomonaga
中科院分区:
文献类型:
--
作者:
K. Nagai;I. Jinnai;T. Hata;T. Usui;D. Sasaki;K. Tsukasaki;K. Sugahara;Y. Hishikawa;Yasuaki Yamada;Yuetsu Tanaka;T. Koji;H. Mano;S. Kamihira;M. Tomonaga
In order to better understand the biology of adult T cell leukemia (ATL), we aimed to establish a novel method, which allows the primary growth of ATL cells using a co-culture system with murine bone marrow-derived stromal cells, MS-5. ATL cells grew in close contact with MS-5 layers and formed so-called “cobblestone areas” (CAs) without the addition of IL-2. In clinical samples, eight of ten (80.0%) cases of acute or lymphoma type ATL cells formed CAs. The frequency of CA forming cells in ATL cells ranged from 0.03 to 1.04%. The morphology, immunophenotyping, and DNA analysis indicated that cells composing CA were compatible with ATL cells, and clonally identical to primary CD4-positive ATL cells. Furthermore, in ATL cells composing CA, the expression of p40Tax was down-regulated in transcriptional and translational level, while that of HTLV-I basic leucine zipper factor (HBZ) gene was comparable to the level of primary ATL cells, resembling expression pattern of proviral genes in in vivo ATL cells. By microarray analysis, several genes which coded products involved in cell–cell interaction, and cellular survival and proliferation, were differentially expressed in ATL cells composing CA compared with primary samples. In conclusion, our co-culture system allows for the first time the growth of primary ATL cells in vitro, and might be useful as an in vitro assay for biological and clinical studies to develop molecular targeting drugs against ATL.
影响因子:
32.4
作者:
Bajenoff, Marc;Egen, Jackson G.;Germain, Ronald N.
通讯作者:
Germain, Ronald N.